Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02349152 · ClinicalTrials.gov registry record · Phase 4
Remifentanil and Glycemic Response in Cardiac Surgery
A Phase 4 study, sponsored by Kathirvel Subramaniam.
- Completed
- Registry status
- Phase 4
- Development phase
- 116
- Enrollment target
NCT02349152: Completed Phase 4 study, sponsored by Kathirvel Subramaniam.
NCT02349152 is a Phase 4 study that has completed, run by Kathirvel Subramaniam. The registered enrollment target is 116 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02349152, a Phase 4 study, has completed, sponsored by Kathirvel Subramaniam.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 116 participants
- Enrollment target
Study Summary
This study evaluates the effect of using remifentanil during cardiopulmonary bypass surgery to supress the hyperglycemic response in perioperative period. Half of the participants will receive continuous intravenous remifentanil during surgery, while the other half will receive intermittent intravenous fentanyl during surgery. Intermittent intravenous fentanyl administration is this institution's standard of care.
Primary Outcome
Percentage of patients with two or more intraoperative blood glucose levels greater than 180 mg/dl. Percentage in both groups will be estimated, then the difference in this statistic will form the primary outcome measure of this study. (Primary Outcome changed on 06/15/2015-Change Approved by University of Pittsburgh IRB on 06/22/2015- First patient enrolled January 2016)
Interventions
- DRUG Fentanyl
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
What the finished NCT02349152 record still lists
NCT02349152 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Fentanyl is the first listed.
NCT02349152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02349152 about?
NCT02349152 is a clinical study titled "Remifentanil and Glycemic Response in Cardiac Surgery". This study evaluates the effect of using remifentanil during cardiopulmonary bypass surgery to supress the hyperglycemic response in perioperative period. Half of the participants will receive continuous intravenous remifentanil during surgery, while the other half will receive intermittent intraven...
What is the current status of trial NCT02349152?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 116 participants. The study started on 2016-01. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02349152?
The interventions under investigation include: Fentanyl (DRUG), Remifentanil (DRUG).
Who is sponsoring clinical trial NCT02349152?
This trial is sponsored by Kathirvel Subramaniam, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02349152's enrollment target sits among peer trials
116 714th of 2000 higher than 1,283 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia